vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $76.2M, roughly 1.2× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -98.1%, a 105.5% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 25.5%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 22.7%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

HIVE vs VMD — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.2× larger
HIVE
$93.1M
$76.2M
VMD
Growing faster (revenue YoY)
HIVE
HIVE
+193.0% gap
HIVE
218.6%
25.5%
VMD
Higher net margin
VMD
VMD
105.5% more per $
VMD
7.4%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
22.7%
VMD

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
VMD
VMD
Revenue
$93.1M
$76.2M
Net Profit
$-91.3M
$5.6M
Gross Margin
-27.1%
57.9%
Operating Margin
11.0%
Net Margin
-98.1%
7.4%
Revenue YoY
218.6%
25.5%
Net Profit YoY
-234.0%
30.7%
EPS (diluted)
$-0.38
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
VMD
VMD
Q4 25
$93.1M
$76.2M
Q3 25
$87.3M
$71.9M
Q2 25
$45.6M
$63.1M
Q1 25
$59.1M
Q4 24
$29.2M
$60.7M
Q3 24
$22.6M
$58.0M
Q2 24
$32.2M
$55.0M
Q1 24
$50.6M
Net Profit
HIVE
HIVE
VMD
VMD
Q4 25
$-91.3M
$5.6M
Q3 25
$-15.8M
$3.5M
Q2 25
$35.0M
$3.2M
Q1 25
$2.6M
Q4 24
$68.2M
$4.3M
Q3 24
$80.0K
$3.9M
Q2 24
$-18.3M
$1.5M
Q1 24
$1.6M
Gross Margin
HIVE
HIVE
VMD
VMD
Q4 25
-27.1%
57.9%
Q3 25
4.7%
57.5%
Q2 25
-13.6%
58.3%
Q1 25
56.3%
Q4 24
-43.7%
59.5%
Q3 24
-66.1%
59.3%
Q2 24
-7.4%
59.8%
Q1 24
58.9%
Operating Margin
HIVE
HIVE
VMD
VMD
Q4 25
11.0%
Q3 25
7.8%
Q2 25
8.1%
Q1 25
6.5%
Q4 24
10.6%
Q3 24
9.7%
Q2 24
6.6%
Q1 24
4.4%
Net Margin
HIVE
HIVE
VMD
VMD
Q4 25
-98.1%
7.4%
Q3 25
-18.1%
4.9%
Q2 25
76.8%
5.0%
Q1 25
4.4%
Q4 24
233.2%
7.1%
Q3 24
0.4%
6.7%
Q2 24
-56.7%
2.7%
Q1 24
3.2%
EPS (diluted)
HIVE
HIVE
VMD
VMD
Q4 25
$-0.38
$0.14
Q3 25
$-0.07
$0.09
Q2 25
$0.18
$0.08
Q1 25
$0.06
Q4 24
$0.52
$0.10
Q3 24
$0.00
$0.10
Q2 24
$-0.17
$0.04
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$141.5M
Total Assets
$624.0M
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
VMD
VMD
Q4 25
$13.5M
Q3 25
$11.1M
Q2 25
$20.0M
Q1 25
$10.2M
Q4 24
$40.5M
$17.5M
Q3 24
$31.7M
$11.3M
Q2 24
$8.8M
Q1 24
$7.3M
Stockholders' Equity
HIVE
HIVE
VMD
VMD
Q4 25
$559.3M
$141.5M
Q3 25
$624.6M
$133.6M
Q2 25
$560.5M
$139.7M
Q1 25
$134.8M
Q4 24
$430.9M
$131.4M
Q3 24
$275.5M
$125.0M
Q2 24
$268.6M
$119.4M
Q1 24
$116.3M
Total Assets
HIVE
HIVE
VMD
VMD
Q4 25
$624.0M
$199.2M
Q3 25
$693.0M
$202.4M
Q2 25
$628.7M
$184.6M
Q1 25
$178.1M
Q4 24
$478.6M
$177.1M
Q3 24
$334.7M
$169.5M
Q2 24
$163.9M
Q1 24
$154.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
VMD
VMD
Operating Cash FlowLast quarter
$46.0M
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
VMD
VMD
Q4 25
$46.0M
$18.4M
Q3 25
$-10.6M
$18.4M
Q2 25
$10.2M
$12.3M
Q1 25
$2.9M
Q4 24
$-28.5M
$15.0M
Q3 24
$-2.2M
$12.7M
Q2 24
$-4.4M
$10.2M
Q1 24
$1.2M
Free Cash Flow
HIVE
HIVE
VMD
VMD
Q4 25
$9.7M
Q3 25
$10.7M
Q2 25
$4.1M
Q1 25
$-12.6M
Q4 24
$-55.5M
$3.2M
Q3 24
$-34.7M
$1.7M
Q2 24
$1.2M
Q1 24
$-4.8M
FCF Margin
HIVE
HIVE
VMD
VMD
Q4 25
12.7%
Q3 25
14.9%
Q2 25
6.5%
Q1 25
-21.4%
Q4 24
-189.9%
5.2%
Q3 24
-153.4%
3.0%
Q2 24
2.3%
Q1 24
-9.5%
Capex Intensity
HIVE
HIVE
VMD
VMD
Q4 25
11.5%
Q3 25
10.6%
Q2 25
12.9%
Q1 25
26.2%
Q4 24
92.5%
19.5%
Q3 24
143.9%
19.0%
Q2 24
16.3%
Q1 24
11.9%
Cash Conversion
HIVE
HIVE
VMD
VMD
Q4 25
3.27×
Q3 25
5.23×
Q2 25
0.29×
3.88×
Q1 25
1.09×
Q4 24
-0.42×
3.47×
Q3 24
-26.94×
3.29×
Q2 24
6.94×
Q1 24
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons